Flputnam Investment Management Co. Raises Stock Position in Zoetis Inc. $ZTS

Key Points

• Flputnam Investment Management increased its Zoetis stake by 1,595.7% in the second quarter, ending with 30,218 shares valued at approximately $2.17 million. Institutional investors and hedge funds collectively own 92.8% of the company.
• Analyst sentiment remains mixed, with a consensus “Hold” rating and an average price target of $109.62 after several firms reduced their targets.
• Zoetis reported quarterly earnings of $1.87 per share, slightly above estimates, while revenue of $2.47 billion fell short of expectations and declined slightly year over year. The company also announced a quarterly dividend of $0.53 per share, representing a 2.9% yield.

Flputnam Investment Management Co. lifted its holdings in Zoetis Inc. (NYSE:ZTS - Free Report) by 1,595.7% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 30,218 shares of the company's stock after purchasing an additional 28,436 shares during the period. Flputnam Investment Management Co.'s holdings in Zoetis were worth $2,171,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in Zoetis by 12.9% in the fourth quarter. Vanguard Group Inc. now owns 47,780,974 shares of the company's stock valued at $6,011,802,000 after acquiring an additional 5,474,210 shares in the last quarter. J. Stern & Co. LLP increased its position in shares of Zoetis by 12,431.2% in the 4th quarter. J. Stern & Co. LLP now owns 24,069,492 shares of the company's stock valued at $3,028,423,000 after purchasing an additional 23,877,416 shares during the last quarter. State Street Corp raised its holdings in shares of Zoetis by 0.8% in the 4th quarter. State Street Corp now owns 19,796,891 shares of the company's stock valued at $2,490,845,000 after purchasing an additional 149,382 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Zoetis by 1.7% during the 4th quarter. Geode Capital Management LLC now owns 11,327,679 shares of the company's stock worth $1,420,294,000 after purchasing an additional 189,235 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of Zoetis during the fourth quarter worth $734,425,000. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have recently issued reports on ZTS. JPMorgan Chase & Co. lowered their price objective on Zoetis from $130.00 to $115.00 and set an "overweight" rating for the company in a research report on Friday, August 7th. William Blair reaffirmed a "market perform" rating on shares of Zoetis in a report on Thursday, August 6th. Stifel Nicolaus dropped their price target on shares of Zoetis from $95.00 to $85.00 and set a "hold" rating on the stock in a research note on Friday, June 26th. HSBC cut their price objective on shares of Zoetis from $140.00 to $95.00 and set a "buy" rating on the stock in a report on Monday, July 6th. Finally, Weiss Ratings cut shares of Zoetis from a "sell (d+)" rating to a "sell (d)" rating in a report on Friday, June 12th. Eight analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $109.62.

Zoetis Trading Down 1.5%

NYSE ZTS opened at $72.71 on Tuesday. The firm's fifty day moving average is $76.17 and its two-hundred day moving average is $98.47. Zoetis Inc. has a one year low of $71.00 and a one year high of $160.48. The company has a debt-to-equity ratio of 2.87, a quick ratio of 1.84 and a current ratio of 3.08. The firm has a market cap of $30.05 billion, a PE ratio of 11.98, a P/E/G ratio of 1.28 and a beta of 0.73.

Zoetis (NYSE:ZTS - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $1.87 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.02. The business had revenue of $2.47 billion during the quarter, compared to the consensus estimate of $2.50 billion. Zoetis had a net margin of 27.49% and a return on equity of 74.89%. The business's quarterly revenue was down .2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.76 earnings per share. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. Analysts expect that Zoetis Inc. will post 6.19 earnings per share for the current year.

Zoetis Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Stockholders of record on Monday, July 20th will be paid a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Monday, July 20th. Zoetis's dividend payout ratio is 34.93%.

Zoetis Profile

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source